List view / Grid view
24 May 2018 | By European Pharmaceutical Review
Percutaneous coronary intervention (PCI), along with prescribed medication, is better than medication alone as initial treatment for people with the most common form of heart disease.
21 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Pregnant mothers may use rheumatoid arthritis drugs without increased health risks to unborn baby...
10 May 2018 | By European Pharmaceutical Review
The U.S. Food and Drug Administration has approved Tafinlar and Mekinist administered together, for the treatment of anaplastic thyroid cancer that cannot be removed by surgery...
10 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Scientists have identified a mutation that gives cancer cells resistance to the breakthrough cancer treatment olaparib and other PARP inhibitors...
4 May 2018 | By European Pharmaceutical Review
Non-aspirin non-steroidal anti-inflammatory medications have been found to have a negative impact on overall and progression-free survival time for mRCC patients...
3 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
The breast cancer drug lapatinib which is designed to shrink tumours can sometimes cause them to grow in the lab...
26 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Long-term use of some anticholinergic medications are associated with an increased risk of dementia – according to a new study led by the University of East Anglia...
24 April 2018 | By European Pharmaceutical Review
Scientists have tried combining drugs in an effort to prevent resistance development that eventually leads to cancer regrowth in melanoma patients.
18 April 2018 | By European Pharmaceutical Review
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings...
16 April 2018 | By European Pharmaceutical Review
In this In-Depth Focus; enabling the manufacture of robust biologic drug products, automating biopharmaceutical development, and greater compatibility and ease of use for bioproduction monitoring of monoclonal antibodies.
5 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A new cancer drug has proven safe and effective for paediatric patients with a rare tumour gene mutation...
5 April 2018 | By European Pharmaceutical Review
Researchers are studying how frequently healthcare providers prescribe potentially inappropriate medications like anticholinergics to older adults.
23 March 2018 | By Infectious Diseases Data Observatory
A pioneering academic conference will bring together, for the first time, people from all over the world dealing with the problem of poor quality medicines and their impact on public health...
22 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
The use of certain diabetes drugs, known as dipeptidyl peptidase-4 inhibitors, are associated with an increased risk of inflammatory bowel disease...
15 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Human tissue samples linked by microfluidic channels replicate interactions of multiple organs.
Send this to a friend
Follow: